[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUND

The present invention relates to a novel [1,2,4]triazolo[1,5-a] pyrimidin-yl derivative as inhibitor of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compound, to processes for preparing such compound and compositions, and to the use of such...

Full description

Saved in:
Bibliographic Details
Main Authors PETRUS JACOBUS JOHANNES ANTONIUS BUIJNSTERS, WILHELMUS, HELENA IGNATIUS MARIA DRINKENBURG, ABDALLAH AHNAOU, HENRICUS JACOBUS MARIA GIJSEN
Format Patent
LanguageEnglish
Published 15.12.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present invention relates to a novel [1,2,4]triazolo[1,5-a] pyrimidin-yl derivative as inhibitor of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compound, to processes for preparing such compound and compositions, and to the use of such compound and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorders.
AbstractList The present invention relates to a novel [1,2,4]triazolo[1,5-a] pyrimidin-yl derivative as inhibitor of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compound, to processes for preparing such compound and compositions, and to the use of such compound and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorders.
Author PETRUS JACOBUS JOHANNES ANTONIUS BUIJNSTERS
WILHELMUS, HELENA IGNATIUS MARIA DRINKENBURG
HENRICUS JACOBUS MARIA GIJSEN
ABDALLAH AHNAOU
Author_xml – fullname: PETRUS JACOBUS JOHANNES ANTONIUS BUIJNSTERS
– fullname: WILHELMUS, HELENA IGNATIUS MARIA DRINKENBURG
– fullname: ABDALLAH AHNAOU
– fullname: HENRICUS JACOBUS MARIA GIJSEN
BookMark eNrjYmDJy89L5WTQjTbUMdIxiQ0J8nSM8vfxB3JNdR1jAyKDPH09XTz9dM11I30UnP19A_xD_Vx4GFjTEnOKU3mhNDeDnJtriLOHbmpBfnxqcUFicmpeakm8b6ShpYm5gYGjMUEFAMRGJgM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID MY194700A
GroupedDBID EVB
ID FETCH-epo_espacenet_MY194700A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:25:21 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MY194700A3
Notes Application Number: MY2018PI00611
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221215&DB=EPODOC&CC=MY&NR=194700A
ParticipantIDs epo_espacenet_MY194700A
PublicationCentury 2000
PublicationDate 20221215
PublicationDateYYYYMMDD 2022-12-15
PublicationDate_xml – month: 12
  year: 2022
  text: 20221215
  day: 15
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies JANSSEN PHARMACEUTICA NV
RelatedCompanies_xml – name: JANSSEN PHARMACEUTICA NV
Score 3.4460075
Snippet The present invention relates to a novel [1,2,4]triazolo[1,5-a] pyrimidin-yl derivative as inhibitor of phosphodiesterase 2 (PDE2). The invention is also...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUND
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221215&DB=EPODOC&locale=&CC=MY&NR=194700A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LS8NAEB5qFfWmVeuz9CA5dTFJs9nmECTNg1aaByGVRiklG1LxUouN-PedDal66W0fMLs7MDv7zWsB7tVBZuioSgg1VJ1oBaMk49qSFP1soBeGwlllGvADfTTVnmZ01oC3bS5MVSf0uyqOiBKVo7yX1X29_jNiOVVs5eaBv-PQx6OXmI5Uo2NVFcUSJGdoulHohLZk26afSkFsIlZnsmztwb54Q4si--7zUKSkrP_rE-8EDiIktSpPoVGsWnBkb79da8GhX3u7sVkL3uYMyKvSU3vaPInH1ks4CbFLiTWP0hgvH2ccEEbSSdcO_SicBs45dDw3sUcE1138nnDhp_X--hfQRNhfXEJX-L11jmiALREEUZVnuczEZ-cs45mey1fQ3kHkeufMDRwLJolwDIXeQrP8_CruUKmWvFMx5Ae1cHa_
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8JAEJ4gGvGm-H4gB9MTG0tpu_TQmLItAe0rpBiqIU23KcYLEqnx7zvbFPXCbR_J7O4kM5NvZmcG4E7pp4aOpoRohqITNacaSbm6IHkv7eu50eW0dA14vj6aqo8zbVaDt00uTFkn9LssjogSlaG8F6W-Xv05sezyb-X6nr_j0sfDMDJtqULHiiKKJUj2wHTCwA6YxJjpxZI_MRGrU1m2dmCXIh4URfad54FISVn9tyfDQ9gLkdSyOIJavmxCg23arjVh36ui3TisBG99DOS121E66jyajK2XwA1wqhFrHsYTVD722CeUxG6bBV4YTH37BFpDJ2Ijgucmvy9MvLi6X-8U6gj783Noi7i3zhEN0AWCIE3haSZT0eycpjzVM_kCzrYQudy6cwuNUeS5iTv2n67gQDBMfM3oatdQLz6_8hs0sAVvlcz5AWjKeao
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%5B1%2C2%2C4%5DTRIAZOLO%5B1%2C5-A%5DPYRIMIDIN-7-YL+COMPOUND&rft.inventor=PETRUS+JACOBUS+JOHANNES+ANTONIUS+BUIJNSTERS&rft.inventor=WILHELMUS%2C+HELENA+IGNATIUS+MARIA+DRINKENBURG&rft.inventor=ABDALLAH+AHNAOU&rft.inventor=HENRICUS+JACOBUS+MARIA+GIJSEN&rft.date=2022-12-15&rft.externalDBID=A&rft.externalDocID=MY194700A